Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies (Q112052448)
Jump to navigation
Jump to search
scientific article published on 7 December 2021
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies |
scientific article published on 7 December 2021 |
Statements
Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies (English)
0 references
7 December 2021
0 references